We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+9.69%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$13.7B
AUM Growth
-$178M
Cap. Flow
-$1.14B
Cap. Flow %
-8.27%
Top 10 Hldgs %
25.57%
Holding
3,040
New
254
Increased
776
Reduced
1,044
Closed
100

Sector Composition

Rank Sector Weight
1 Technology 26.03%
2 Healthcare 12.56%
3 Financials 11.14%
4 Consumer Discretionary 11.02%
5 Industrials 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NTLA icon
951
Intellia Therapeutics
NTLA
$1.66B
$1.9M 0.01%
46,496
+2,465
+6% +$100K
ALGM icon
952
Allegro MicroSystems
ALGM
$7.92B
$1.89M 0.01%
41,885
-710
-2% -$28.7K
WRK
953
DELISTED
WestRock Company
WRK
$1.89M 0.01%
64,963
-724
-1% -$21K
NWSA icon
954
News Corp Class A
NWSA
$15.5B
$1.89M 0.01%
96,679
-1,939
-2% -$35.2K
TNET icon
955
TriNet
TNET
$3.07B
$1.88M 0.01%
19,812
+196
+1% +$17.8K
HP icon
956
Helmerich & Payne
HP
$4.29B
$1.88M 0.01%
53,049
-1,312
-2% -$44.7K
CABO icon
957
Cable One
CABO
$191M
$1.88M 0.01%
2,862
-257
-8% -$173K
HI
958
DELISTED
Hillenbrand
HI
$1.88M 0.01%
36,665
+308
+0.8% +$14.8K
XRX icon
959
Xerox
XRX
$412M
$1.88M 0.01%
125,993
+49
+0% +$717
GPI icon
960
Group 1 Automotive
GPI
$3.17B
$1.87M 0.01%
7,246
-163
-2% -$37.5K
FOLD
961
DELISTED
Amicus Therapeutics
FOLD
$1.87M 0.01%
148,666
+2,243
+2% +$26.6K
SKY icon
962
Champion Homes
SKY
$5.23B
$1.87M 0.01%
28,525
+251
+0.9% +$17.1K
EPRT icon
963
Essential Properties Realty Trust
EPRT
$6.62B
$1.85M 0.01%
78,540
+5,486
+8% +$134K
ENOV icon
964
Enovis
ENOV
$1.42B
$1.85M 0.01%
28,828
-452
-2% -$25.7K
KMPR icon
965
Kemper
KMPR
$1.56B
$1.85M 0.01%
38,272
-939
-2% -$45.5K
SAM icon
966
Boston Beer
SAM
$1.89B
$1.85M 0.01%
5,988
-151
-2% -$48.6K
DNLI icon
967
Denali Therapeutics
DNLI
$3.97B
$1.84M 0.01%
62,264
+5,237
+9% +$147K
SANM icon
968
Sanmina
SANM
$11.2B
$1.83M 0.01%
30,317
+344
+1% +$18.9K
BRSL
969
Brightstar Lottery PLC
BRSL
$2.15B
$1.83M 0.01%
57,280
+5,901
+11% +$164K
AZTA icon
970
Azenta
AZTA
$1.47B
$1.83M 0.01%
39,110
-3,246
-8% -$142K
ARRY icon
971
Array Technologies
ARRY
$796M
$1.82M 0.01%
80,619
+1,045
+1% +$22.4K
FRT icon
972
Federal Realty Investment Trust
FRT
$10.2B
$1.82M 0.01%
18,766
-272
-1% -$25.6K
TGTX icon
973
TG Therapeutics
TGTX
$7.58B
$1.8M 0.01%
72,322
+2,226
+3% +$57.5K
TWNK
974
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$1.79M 0.01%
70,525
+527
+0.8% +$13.5K
AMED
975
DELISTED
Amedisys
AMED
$1.78M 0.01%
19,516
-397
-2% -$32.6K

Similar funds

MetLife Investment Management's Q2 2023 Portfolio in Review

As of Q2 2023, MetLife Investment Management held 3,040 positions worth $13.7B, down 1.3% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

MetLife Investment Management withdrew a net $1.14B in Q2 2023, closing 100 positions and reducing 1,044 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $3.05M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, MetLife Investment Management opened a new position in Knife River worth $2.46M.

  • MetLife Investment Management's largest Q2 2023 buy was Knife River: 56,478 shares worth $2.46M.
  • MetLife Investment Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $14.9M increase.
  • MetLife Investment Management's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $901M.
  • MetLife Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $3.05M.
  • MetLife Investment Management's ten largest holdings make up 26% of its $13.7B portfolio in Q2 2023.
  • MetLife Investment Management opened 254 new positions and closed 100 in Q2 2023.
  • MetLife Investment Management's portfolio value fell 1.3% quarter-over-quarter to $13.7B.

Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.